Nexalin Technology has been granted a patent by the United States Patent and Trademark Office for its innovative neurostimulation method. This patent recognition underscores the company's commitment to advancing therapeutic technologies aimed at treating neurological conditions. The neurostimulation method is designed to enhance brain function and improve mental health outcomes for patients. This development positions Nexalin as a key player in the field of neurotherapy.
Don't miss out on breaking stories and in-depth articles.
